Bio Protocol vs Starknet — how do they compare? Bio Protocol trades at Rp516 (market cap Rp1,15T, Rp260,42M 24h volume), while Starknet trades at Rp538.1 (market cap Rp3,54T, Rp204,27M 24h volume). The key difference: Starknet is far larger — about 3.1× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Starknet's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Starknet for 73 Days on average.
| BIO | STRK | |
|---|---|---|
Market Cap | Rp1,15T | Rp3,54T |
Volume (24h) | Rp260,42M | Rp204,27M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 6,6B STRK |
Typical Hold Time | 16 Days | 73 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Starknet (STRK) is currently trading at Rp536.31 with a market cap of Rp3.52T, showing a bearish technical outlook as moving averages signal strong selling pressure and oscillators remain neutral. Key support lies at Rp533 and resistance at Rp550. Recent news highlights ongoing crypto market weakness, though some analysts rate STRK a BUY for yield-seeking crypto investors. The token's hold time of 73 days suggests moderate investor retention amid market volatility.
Overall outlook is cautious due to bearish technicals and broader crypto market slump. Opportunities include potential rebounds from oversold RSI levels and high-yield appeal. Major risks involve continued selling pressure, low liquidity, and regulatory uncertainties. Investors should monitor support levels and ecosystem updates closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →StarkNet is a permissionless decentralized Validity-Rollup (also known as a “ZK-Rollup”). It operates as an L2 network over Ethereum, enabling any dApp to achieve unlimited scale for its computation—without compromising Ethereum’s composability and security, thanks to StarkNet’s reliance on the safest and most scalable cryptographic proof system—STARK.
Read more on STRK →